Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center Clinical Performance Evaluation of the NeuMoDx™ Chlamydia Trachomatis (CT) / Neisseria Gonorrhoeae (NG) [CT/NG] Assay on the NeuMoDx™ 288 Molecular System and the NeuMoDx™96 Molecular System

NCT03970850 is registered in ClinicalTrials.gov with NeuMoDx Molecular, Inc. as lead sponsor.

NCT NCT03970850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03970850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center Clinical Performance Evaluation of the NeuMoDx™ Chlamydia Trachomatis (CT) / Neisseria Gonorrhoeae (NG) [CT/NG] Assay on the NeuMoDx™ 288 Molecular System and the NeuMoDx™96 Molecular System
Lead sponsor
NeuMoDx Molecular, Inc.
Phase
Not applicable
Overall status
Completed
Start date
July 22, 2019
Completion date
February 25, 2020
Enrollment
4,017 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

chlamydia trachomatis infection, neisseria gonorrheae infection